LERITONE TDAH- ADHD- ADVANCED - AVANCÉ
Natural health product licensed in Canada
- Other names
- LERITONE GENIUS TDAH-ADHD - ADVANCED- AVANCÉ
- Licence holder
- IRB Yves Ponroy Canada Inc.
- NPN or DIN-HM
- 80083836
- Status
- Active licence
- Licence date
- 16 March 2018
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Clupeidae - en entier Potency : 250 mg Acide éicosapentaénoïque | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 250 mg Acide éicosapentaénoïque | Not specified | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 250 mg Acide éicosapentaénoïque | Not specified | Not calculated |
| Clupea harengus Source : Oeuf de hareng Extract : Matériel brut frais Extraction ratio : 4:1 Dry plant equivalent : 359.6 mg Potency : 25 mg Phospholipides | 89.9 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 100 mg Acide docosahexaénoïque | 500 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 100 mg Acide docosahexaénoïque | 500 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 100 mg Acide docosahexaénoïque | 500 mg | Not calculated |
| Oenothera biennis Source : Graine(s) Potency : 10 mg Acide gamma-linolénique | 100 mg | Not calculated |
Non-medicinal ingredients
Saveur de citron, Extrait de fruit de monk, Extrait de thé vert, Mélange de concentré de tocophérols, Astaxanthine, Saveur de bubblegum, Palmitate d'ascorbyle, Extrait de feuilles de romarin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4 years ; maximum: 12 years | 2 Cuillère à thé | 1 Tous les jours |
| Adolescentes | minimum: 13 years ; maximum: 18 years | 2 Cuillère à thé | 1 Tous les jours |
Uses authorised in Canada
Pourrait aider dans la prise en charge du TDA et du TDAH / May help in the management of ADD/ADHD. Aide à contrôler les symptômes de TDAH chez les enfants (4-12 ans) et adolescents (13-18 ans). Améliore les niveaux de concentration chez les enfants et adolescents souffrant de trouble de l¿attention avec ou sans hyperactivité. (TDA ou TDAH). Supporte la santé cognitive et les fonctions cérébrales. Aide à la concentration chez les enfants et adolescents souffrant de TDAH. Aide au développement du système nerveux chez les enfants âgés de 12 ans et moins. Supporte le développement du cerveau, des yeux et des nerfs chez les enfants âgés de 12 ans et moins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80083836
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.